186 related articles for article (PubMed ID: 32639951)
1. An individualized transcriptional signature to predict the epithelial-mesenchymal transition based on relative expression ordering.
Chen T; Zhao Z; Chen B; Wang Y; Yang F; Wang C; Dong Q; Liu Y; Liang H; Zhao W; Qi L; Xu Y; Gu Y
Aging (Albany NY); 2020 Jul; 12(13):13172-13186. PubMed ID: 32639951
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients.
Tan TZ; Miow QH; Miki Y; Noda T; Mori S; Huang RY; Thiery JP
EMBO Mol Med; 2014 Oct; 6(10):1279-93. PubMed ID: 25214461
[TBL] [Abstract][Full Text] [Related]
3. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
[TBL] [Abstract][Full Text] [Related]
4. Machine learning-assisted analysis of epithelial mesenchymal transition pathway for prognostic stratification and immune infiltration assessment in ovarian cancer.
Li Q; Xiao X; Feng J; Yan R; Xi J
Front Endocrinol (Lausanne); 2023; 14():1196094. PubMed ID: 37404304
[TBL] [Abstract][Full Text] [Related]
5. Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracy.
Thompson JC; Hwang WT; Davis C; Deshpande C; Jeffries S; Rajpurohit Y; Krishna V; Smirnov D; Verona R; Lorenzi MV; Langer CJ; Albelda SM
Lung Cancer; 2020 Jan; 139():1-8. PubMed ID: 31683225
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-mesenchymal transition gene signature is associated with prognosis and tumor microenvironment in head and neck squamous cell carcinoma.
Jung AR; Jung CH; Noh JK; Lee YC; Eun YG
Sci Rep; 2020 Feb; 10(1):3652. PubMed ID: 32107458
[TBL] [Abstract][Full Text] [Related]
7. The Correlation Between the Immune and Epithelial-Mesenchymal Transition Signatures Suggests Potential Therapeutic Targets and Prognosis Prediction Approaches in Kidney Cancer.
Liang J; Liu Z; Zou Z; Tang Y; Zhou C; Yang J; Wei X; Lu Y
Sci Rep; 2018 Apr; 8(1):6570. PubMed ID: 29700419
[TBL] [Abstract][Full Text] [Related]
8. A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome.
Schell MJ; Yang M; Missiaglia E; Delorenzi M; Soneson C; Yue B; Nebozhyn MV; Loboda A; Bloom G; Yeatman TJ
Clin Cancer Res; 2016 Feb; 22(3):734-45. PubMed ID: 26446941
[TBL] [Abstract][Full Text] [Related]
9. ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells.
Yeung TL; Leung CS; Wong KK; Gutierrez-Hartmann A; Kwong J; Gershenson DM; Mok SC
Oncotarget; 2017 Mar; 8(10):16951-16963. PubMed ID: 28199976
[TBL] [Abstract][Full Text] [Related]
10. Comparative gene co-expression network analysis of epithelial to mesenchymal transition reveals lung cancer progression stages.
Wang D; Haley JD; Thompson P
BMC Cancer; 2017 Dec; 17(1):830. PubMed ID: 29212455
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition polarization in ovarian carcinomas from patients with high social isolation.
Lutgendorf SK; Penedo F; Goodheart MJ; Dahmoush L; Arevalo JMG; Thaker PH; Slavich GM; Sood AK; Cole SW
Cancer; 2020 Oct; 126(19):4407-4413. PubMed ID: 32691853
[TBL] [Abstract][Full Text] [Related]
12. Alteration of epithelial-mesenchymal transition markers in human normal ovaries and neoplastic ovarian cancers.
Yi BR; Kim TH; Kim YS; Choi KC
Int J Oncol; 2015 Jan; 46(1):272-80. PubMed ID: 25310727
[TBL] [Abstract][Full Text] [Related]
13. Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120).
Huang RY; Kuay KT; Tan TZ; Asad M; Tang HM; Ng AH; Ye J; Chung VY; Thiery JP
Oncotarget; 2015 Sep; 6(26):22098-113. PubMed ID: 26061747
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome profiling reveals novel gene expression signatures and regulating transcription factors of TGFβ-induced epithelial-to-mesenchymal transition.
Du L; Yamamoto S; Burnette BL; Huang D; Gao K; Jamshidi N; Kuo MD
Cancer Med; 2016 Aug; 5(8):1962-72. PubMed ID: 27318801
[TBL] [Abstract][Full Text] [Related]
15. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
[TBL] [Abstract][Full Text] [Related]
16. Identifying global expression patterns and key regulators in epithelial to mesenchymal transition through multi-study integration.
Parsana P; Amend SR; Hernandez J; Pienta KJ; Battle A
BMC Cancer; 2017 Jun; 17(1):447. PubMed ID: 28651527
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer.
Zhang Z; Yu Y; Li P; Wang M; Jiao W; Liang Y; Niu H
Front Immunol; 2022; 13():954616. PubMed ID: 35958586
[TBL] [Abstract][Full Text] [Related]
18. Identification of 9-Gene Epithelial-Mesenchymal Transition Related Signature of Osteosarcoma by Integrating Multi Cohorts.
Yiqi Z; Ziyun L; Qin F; Xingli W; Liyu Y
Technol Cancer Res Treat; 2020; 19():1533033820980769. PubMed ID: 33308057
[TBL] [Abstract][Full Text] [Related]
19. CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways.
Nakamura K; Terai Y; Tanabe A; Ono YJ; Hayashi M; Maeda K; Fujiwara S; Ashihara K; Nakamura M; Tanaka Y; Tanaka T; Tsunetoh S; Sasaki H; Ohmichi M
Oncol Rep; 2017 Jun; 37(6):3189-3200. PubMed ID: 28440503
[TBL] [Abstract][Full Text] [Related]
20. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]